NEW YORK (Reuters Health) – Adjuvant radiation following radical prostatectomy (RP) seemed more effective in reducing all-cause mortality (ACM) than salvage radiation in men with high-risk prostate cancer in a large retrospective study. “The study will likely change the standard of care,” Dr. Anthony D’Amico of Brigham and Women’s Hospital in Boston told Reuters Health […]

NEW YORK (Reuters Health) – Tumor genomic factors differed substantially between African-American men (AAM) and European-American men (EAM) who underwent radical prostatectomy, potentially revealing a basis for racial disparity in prostate cancer, a retrospective analysis shows. “This study is the logical extension of our ongoing efforts to combat the racial disparity,” Dr. Ash Tewari of […]

Might more prostate-specific antigen (PSA) testing in younger African American men (40-55 years old) be a key to reducing their relatively high mortality rates from prostate cancer compared to same-aged White men? New observational research cannot definitively say yes or no, but it does indicate that  increased intensity of PSA screening was associated with decreased […]